Get a comprehensive overview from regulators and industry experts on the process of designing and conducting clinical trials from phase I through to phases II and III at our two-day Understanding Clinical Development CRED course.
By attending this in-person training course on 15-16 October 2024 in London you will:
✅ Optimise your clinical development programme
✅ Design clinical trials to support proof of efficacy
✅ Build a network that will support you for the rest of your career
✅ Earn 15.5 CPD hours
Our industry experts, like Carly Barraclough from Amgen Ltd, Glyn Belcher from PV Consultancy Ltd, Beatrix Friedeberg from Vertex Pharmaceuticals, Steve Pinder from Envestia Ltd, Marco Siccardi from Labcorp and Jana Zizkovska from the State Institute for Drug Control (SUKL) will share their knowledge and experience to help you strengthen your understanding of the points to consider when designing a clinical development programme that supports and extends beyond a marketing application.
This course is part of our programme of CRED courses which are for experienced professionals committed to developing their regulatory and management competencies.
Discounted rates are available TOPRA members and for those working for regulatory or government agencies, academic institutions, charities, patient groups, or in full time education.
